Also trades as: CMRAW (NASDAQ) · $vol 0M
CMRA OTC
Comera Life Sciences Holdings, Inc.
1W: -0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.0001-0.0001
Volume730
Avg Volume948
Beta1.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael G. Campbell
Employees12
SectorHealthcare
IndustryBiotechnology
IPO Date2020-12-21
Websitecomeralifesciences.com
12 Gill Street
Woburn, MA 01801
US
Woburn, MA 01801
US
617 871 2101
About Comera Life Sciences Holdings, Inc.
Comera Life Sciences Holdings, Inc. is an early-stage biotechnology firm focused on creating its own pipeline of innovative therapies. These treatments leverage its exclusive SQore formulation platform, engineered to transform intravenous (IV) biologic drugs into more convenient subcutaneous (SQ) injectable forms. Currently, the company is progressing two main product candidates: CLS-001, an early-stage "biobetter" designed to treat inflammatory bowel conditions like Crohn's and Ulcerative Colitis, and CLS-002, another preclinical biobetter aimed at diverse oncology indications. Established in 2014, Comera Life Sciences is headquartered in Woburn, Massachusetts.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Konar Shameek | P-Purchase | 0 | $0.06 | 2023-12-29 |
| Konar Shameek | P-Purchase | 4,090,908 | $0.06 | 2023-12-29 |
| DENNY GEORGE P III | P-Purchase | 0 | $0.06 | 2023-12-29 |
| DENNY GEORGE P III | P-Purchase | 3,913,526 | $0.06 | 2023-12-29 |
| HALPERN JOHN D | 4,073,744 | $0.06 | 2023-12-29 |